These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 4591438

  • 21. Study by the isotopic antiglobulin technique of a cross-reacting murine antibody produced by immunization with a syngeneic SV40 tumor.
    Burdick JF, Stemple D, Wells SA.
    Int J Cancer; 1973 Sep 15; 12(2):474-84. PubMed ID: 4365462
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Heterogeneity of virus production and antigenicity detected in cell clones derived from a "nonproducer" neoplasm induced by Moloney murine sarcoma virus.
    Law LW, Chang KS, Nakata K.
    J Natl Cancer Inst; 1974 Feb 15; 52(2):437-43. PubMed ID: 4361177
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Antigens of tumours induced by naturally occurring murine sarcoma virus (MSV-FBJ). I. Detection of group and type specific antigens by complement fixation.
    Jones DB, Moore M.
    Br J Cancer; 1974 Jan 15; 29(1):21-30. PubMed ID: 4820943
    [Abstract] [Full Text] [Related]

  • 29. Loss and recovery of phenotypic expression of Gross leukaemia virus.
    Ioachim HL, Dorsett B, Sabbath M, Keller S.
    Nat New Biol; 1972 Jun 14; 237(76):215-8. PubMed ID: 4113835
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Genetic control of MuLV-gs expression in crosses between high and low leukemia incidence strains.
    Hilgers J, Galesloot J.
    Int J Cancer; 1973 May 14; 11(3):780-93. PubMed ID: 4364724
    [No Abstract] [Full Text] [Related]

  • 32. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M, Rouse BT, Warner NL.
    J Natl Cancer Inst; 1973 Jan 14; 50(1):159-72. PubMed ID: 4571237
    [No Abstract] [Full Text] [Related]

  • 33. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J.
    Ser Haematol; 1972 Jan 14; 5(4):93-122. PubMed ID: 4133765
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Attempted induction of tumor antigens in carcinogen-treated cells.
    Outzen HC, Andrews EJ, Basombrío MA, Litwin S, Prehn RT.
    J Natl Cancer Inst; 1972 Nov 14; 49(5):1295-302. PubMed ID: 4568086
    [No Abstract] [Full Text] [Related]

  • 37. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E, DeLeo AB, O'Donnell PV, Obata Y, Old LJ.
    J Exp Med; 1979 Jan 01; 149(1):200-15. PubMed ID: 216764
    [Abstract] [Full Text] [Related]

  • 38. Immunogenicity and enhancement of normal and tumor tissue in the mouse.
    McKenzie IF, Snell GD.
    Transplant Proc; 1973 Mar 01; 5(1):953-6. PubMed ID: 4572155
    [No Abstract] [Full Text] [Related]

  • 39. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
    Prager MD, Baechtel FS, Ribble RJ, Ludden CM, Mehta JM.
    Cancer Res; 1974 Dec 01; 34(12):3203-9. PubMed ID: 4429949
    [No Abstract] [Full Text] [Related]

  • 40. Effect of immunization on the spread of transplanted mouse lymphoma cells.
    Klein E.
    J Natl Cancer Inst; 1973 Dec 01; 51(6):1991-2. PubMed ID: 4587755
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.